(Q53608389)

English

Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

2

object named as

Yeo-Pyo Yun

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

1

object named as

Tack-Joong Kim

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

publication date

16 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

46

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

43-51

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Synthesis of Toddacoumaquinone, a Coumarin-Naphthoquinone Dimer, and Its Antiviral Activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Effects of apigenin on the serum- and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Cell replication in the arterial wall: activation of signaling pathway following in vivo injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

PDGF ligand and receptor gene expression during repair of arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Inhibitory effects of ochratoxin A on nerve growth factor-induced neurite extension through downregulation of p38 MAP kinase and AP-1 activation in cultured pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

An antifungal naphthoquinone, xanthones and secoiridoids from Swertia calycina.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Cell biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Inhibition of 2-P-mercaptophenyl-1,4-naphthoquinone on human platelet function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Expression of cyclin-dependent kinase inhibitors in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Modulation of growth factor action: implications for the treatment of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Smooth muscle cell proliferation. Expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.06.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2006.06.007

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16875883

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53608389&oldid=2230736172"